Plain Packaging

Comment from Connor Campbell, a senior market analyst at


With Philip Morris blasted by the International Permanent Court of Arbitration for attempting ‘an abuse of rights’ by trying to get graphic cigarette packing banned in Australia the company today stated they would not contest the verdict. This appeared to send its stock 1% lower this afternoon, though given the wider state of the market it is hard to ascertain how much impact the news has actually had.

Royal College of Physicians issues 200 page report advocating smokers switch to vaping

Reprinted with the kind permission of Bill Godshall of Smokefree Pennsylvania

Royal College of Physicians issues 200 page report advocating smokers switch to vaping

Royal College of Physicians – Nicotine Without Smoke: Tobacco Harm Reduction

Promote e-cigarettes widely as substitute for smoking says new RCP report

John Britton: Nicotine without smoke – putting electronic cigarettes in context

Cancer Research UK: Reducing the harm of tobacco, could e-cigarettes be part of the solution?

Cancer group lauds report encouraging vaping use

Mike Siegel: Royal College of Physicians report recommends widespread promotion of electronic cigarettes for smoking cessation

AVA: Switch to vaping to avoid ‘almost all of the harm from smoking,’ says Royal College of Physicians

Vaping Vindicated: The evidence that vaping helps wean smokers off tobacco is overwhelming. The NHS should embrace it as a route to better public health

E-cigarettes should be offered to smokers, say doctors

UK doctors urge wide promotion of e-cigs to help smokers quit

Doctors warn of big tobacco firms entering e-cigarette market

Doctors body strongly promotes e-cigarettes as healthier alternative to smoking as EU rules make them weaker

E-cigarettes could save millions, say doctors

E-cigarettes ‘much less harmful than smoking and should be encouraged’

A major medical group just threw its weight behind e-cigs

GPs advised to ‘promote e-cigarettes widely’ as smoking substitute

Royal College of Physicians study finds e-cigarettes should be widely promoted as substitute for smoking

E-cigarettes help save lives, says Royal College of Physicians

Scotland Herald View: Progress on vaping

Scotsman: Vaping must be allowed to work

Why e-cigarettes should be ‘widely promoted’ as a substitute for smoking

Vaping is about reducing harm, not being harmless

Are e-cigarettes good or bad for you? Everything smokers need to know

UK medical body backs e-cigarettes (from AAP in Australia)

Doctors call for e-cigarettes to be “promoted” – from

Doctors call for e-cigarettes to be “promoted”

KUALA LUMPUR, April 28, 2016 – An extraordinary new report from the top doctors’ organisation in the UK calls e-cigarettes “beneficial to public health”.

The report, from the Royal College of Physicians (RCP*), says smokers should be “encouraged” to switch to e-cigarettes as an alternative to smoking because “the public can be reassured that e-cigarettes are much safer than smoking.”

Findings of the landmark 200-page report – the latest in a line of such positive views on vaping from major independent UK bodies – include:

• e-cigs do NOT ‘re-normalise’ smoking

• e-cigs are a gateway AWAY from smoking

• e-cigs constitute a benefit to public health (in the UK, where they have been made legal and an estimated 2.7 million adults use them – overwhelmingly as part of a process to stop smoking)

• e-cigarettes should be regulated, but in a ‘proportionate’ way. Laws “should not be allowed significantly to inhibit the development and use of harm-reduction products by smokers”

The RCP’s own summary of the report, “Nicotine without smoke: tobacco harm reduction“, says:

“e-cigarettes are likely to be beneficial to UK public health. Smokers can therefore be reassured and encouraged to use them, and the public can be reassured that e-cigarettes are much safer than smoking.

“Although smoking prevalence in the UK has reduced to 18 percent, 8.7 million people still smoke. Harm reduction provides an additional strategy to protect this group of smokers from disability and early death.

“Since e-cigarettes became available in the UK in 2007, their use has been surrounded by medical and public controversy. This new 200-page report examines the science, public policy, regulation and ethics surrounding e-cigarettes and other non-tobacco sources of nicotine, and addresses these controversies and misunderstandings with conclusions based on the latest available evidence:

“E-cigarettes are not a gateway to smoking – in the UK, use of e-cigarettes is limited almost entirely to those who are already using, or have used, tobacco

“E-cigarettes do not result in normalisation of smoking – there is no evidence that either nicotine replacement therapy (NRT) or e-cigarette use has resulted in re-normalisation of smoking. None of these products has to date attracted significant use among adult never-smokers, or demonstrated evidence of significant gateway progression into smoking among young people”E-cigarettes and quitting smoking – among smokers, e-cigarette use is likely to lead to quit attempts that would not otherwise have happened, and in a proportion of these to successful cessation. In this way, e-cigarettes can act as a gateway from smoking

“E-cigarettes and long-term harm – the possibility of some harm from long-term e-cigarette use cannot be dismissed due to inhalation of the ingredients other than nicotine, but is likely to be very small, and substantially smaller than that arising from tobacco smoking. With appropriate product standards to minimise exposure to the other ingredients, it should be possible to reduce risks of physical health still further. Although it is not possible to estimate the long-term health risks associated with e-cigarettes precisely, the available data suggest that they are unlikely to exceed 5% of those associated with smoked tobacco products, and may well be substantially lower than this figure.

“The report acknowledges the need for proportionate regulation, but suggests that regulation should not be allowed significantly to inhibit the development and use of harm-reduction products by smokers. A regulatory strategy should take a balanced approach in seeking to ensure product safety, enable and encourage smokers to use the product instead of tobacco, and detect and prevent effects that counter the overall goals of tobacco control policy.”

Professor John Britton, chair of the RCP’s Tobacco Advisory Group, said:

‘The growing use of electronic cigarettes as a substitute for tobacco smoking has been a topic of great controversy, with much speculation over their potential risks and benefits. This report lays to rest almost all of the concerns over these products, and concludes that, with sensible regulation, electronic cigarettes have the potential to make a major contribution towards preventing the premature death, disease and social inequalities in health that smoking currently causes in the UK. Smokers should be reassured that these products can help them quit all tobacco use forever.’

RCP president Professor Jane Dacre said:

‘Since the RCP’s first report on tobacco, Smoking and Health, in 1962, we have argued consistently for more and better policies and services to prevent people from taking up smoking, and help existing smokers to quit. This new report builds on that work and concludes that, for all the potential risks involved, harm reduction has huge potential to prevent death and disability from tobacco use, and to hasten our progress to a tobacco-free society. With careful management and proportionate regulation, harm reduction provides an opportunity to improve the lives of millions of people. It is an opportunity that, with care, we should take.’

*The Royal College of Physicians, founded in 1518, is the oldest medical college in England. It continues to play a pivotal role in raising standards and shaping public health today and is continuously active in improving the practice of medicine.

is an independent, not-for-profit, consumer-oriented advocate for rational debate about – and sensible regulation of – the rights of adult citizens throughout Asia to choose to use tobacco or other nicotine related products. factasia does not promote smoking or the use of nicotine, opposes all under-age use of cigarettes or any other product containing nicotine, and does not engage in any manufacturing or distribution activities.

* The report will be free to download from the RCP website on Thursday 28 April at:

For more information, please contact:
Heneage Mitchell: +66 95 760 4122, +852 8198 2302
John Boley: +61 484 634 533, +852 6281 3586

Congress moves to help the Vaping industry

House Committee Votes to Save the Vaping Industry

House Appropriations Committee passes amendment to stop the FDA from banning 99%-plus of vapor products

WASHINGTON, D.C. – In a big win for vapers, this afternoon the House Appropriations Committee voted in favor of an amendment to the FY 2017 Agriculture Appropriations bill that would modernize the predicate date for vapor products and stop the FDA from banning 99%-plus of vapor products on the market today.  The bipartisan amendment by Rep. Tom Cole (R – OK) and Rep. Sanford Bishop (D – GA) passed by a 31-19 vote.


Yesterday, Gregory Conley, the President of the American Vaping Association (AVA), warned in an Op Ed published by The Hill that a failure to change the February 15, 2007 predicate date would mean the closure of thousands of small businesses across the country and allow Big Tobacco to take over the vapor product market.


“This is fantastic news for public health and small businesses,” said Conley.  “The vapor industry and its consumers do not oppose sensible regulation, but the FDA’s proposal is anything but sensible.”


“Modernizing the predicate date will not interfere with the FDA’s ability to regulate vapor products.  All this change does is force the agency to regulate the vapor products rather than just ban 99%-plus of products on the market today,” continued Conley.
In addition to changing the predicate date, the Cole-Bishop amendment directs the FDA to set product standards, dictate labeling requirements, require retailer registration to effectuate youth access compliance checks, and ban self-service displays and vending machines in stores that permit minors.  Furthermore, the amendment restricts the advertising of vapor products.


Despite today’s favorable vote, the AVA remains cautious of the process that lies ahead.


“This is only the start of a long fight to keep this provision in the overall budget bill. The industry and its consumers need to put forth a massive effort to ensure that both Democrats and Republicans do not lose sight of the importance of this policy change.”


The 2017 spending and budget bills may not be voted by the full House and Senate until the end of the year, so uncertainty in the market will continue to linger.


“The fate of the U.S. vapor product industry is in the hands of Congress,” says Conley.



BAT results – commentary

British American Tobacco have released their latest earnings. Here’s a comment from Joshua Raymond, Market Analyst at

“British American Tobacco announced a like for like growth in cigarette volume of 1.1% in an interim management update for its nine months to 31st March. The firm saw solid growth in volume sales across a number of important territories including Russia, Turkey and Indonesia which helped to offset lower volumes in Pakistan and Malaysia, which was impacted by higher excise led price increases.


The firm saw revenues grow by 7.5% at constant rates of exchange but once current exchange rates are shown, revenues drop to a mere growth of 1.5%, showing just how much the company has been effected by negative FX moves. The firm also warned that if FX moves continue as they have been, its profits would be impacted to the tune of 7% give how much it relies on such a broad geographical transactional flow.


All in all it seems a fairly solid report sales wise but given how competitive the industry is and its own fairly open ended disclaimer that profit margins would be hit by negative FX moves, there can also be an element of lingering concern here for the firms full year results.”




TPE – Tobacco Plus Expo – Las Vegas, NV show – March 16-18 2016

Well I had a good show and saw lots of my buddies all in one place.

Even so, many commented they did not and complained about the lack of visitors.

In my recent experience this is common. There are simply a lot of tobacco shows around the world and its mostly patronized by the same core visitors.

I like the diversity of TPE and hope it continues……

Fontem Ventures B.V. and VMR Products, LLC, Announce Settlement Agreement In Relation to E-Vapour Technology Patents

Apr 05, 2016, 04:41 ET from Fontem Ventures B.V.

AMSTERDAM, April 5, 2016 /PRNewswire/ —

Fontem Ventures, owner of market leading e-cigarette brand blu, and VMR Products, LLC, a U.S. based distributor and retailer of vaporizers and e-liquids, today announced they have reached a settlement agreement that resolves ongoing litigation in the USA.

The settlement ends the last of eight patent infringement cases originally brought by Fontem Ventures and Fontem Holdings 1 in March 2014 in the United States District Court for the Central District of California in relation to e-vapour technology.

Under the terms of the settlement, Fontem Ventures has granted VMR Products, LLC a non-exclusive royalty-bearing licence under the patents asserted in the litigation and certain other e-vapour technology related patents. The remaining settlement terms are confidential.

About Fontem Ventures*

Fontem Ventures is the owner of blu, a leading e-cigarette brand in the United States and the United Kingdom. Headquartered in the Netherlands, and present on two continents, Fontem Ventures is an innovative consumer goods company, founded in 2012, committed to developing a portfolio of products that meet consumer needs, including the highest quality electronic vaping products.

About VMR*

Founded in 2009, VMR Products is a global force in the vapor products industry. The company’s flagship brands; V2®, V2 Pro®, Vapour2™, and Vapor Couture™, are sold in many countries. VMR designs, produces, distributes and supports an expanding catalog of quality products, and is an OEM manufacturer for a long list of private-label brands, including Zig-Zag®, OCB®, ECG®, and QuickDraw®. VMR is the only electronic cigarette company to employ a vertically integrated business model, managing its entire product life cycle to ensure the highest commitment to quality control and customer service.®, is the world’s highest volume online retailer of electronic cigarettes and personal vaporizers, and has maintained this position since 2011. The company has distinguished itself as an industry leader with its ever-expanding product lines, powerful vapor production and great taste.

*The information provided in “About Fontem Ventures” and “About VMR” is made solely by each respective party without review or confirmation as to accuracy by the other party.

SOURCE Fontem Ventures B.V.

Eliquids / juices

How do consumers decide which juices to buy and why??

There are a lot of choices out there….perhaps too many??

What are your favorite flavors??